Skip to Content

Nature's Bounty Red Krill Oil (omega-3 polyunsaturated fatty acids) Disease Interactions

There are 2 disease interactions with Nature's Bounty Red Krill Oil (omega-3 polyunsaturated fatty acids):

Moderate

Omega-3 fatty acids (applies to Nature's Bounty Red Krill Oil) arrhythmias

Moderate Potential Hazard, Moderate plausibility.

Cases of recurrent atrial fibrillation (AF) or flutter have been reported with the use of omega-3 fatty acids in patients with a symptomatic paroxysmal AF or persistent AF. This condition is more apparent within the first 2 to 3 months after the initiation of therapy. Therapy with these agents should be administered cautiously in patients with cardiac conduction disorders.

Moderate

Omega-3 fatty acids (applies to Nature's Bounty Red Krill Oil) liver disease

Moderate Potential Hazard, Moderate plausibility.

Increases in alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) levels have been observed in patients receiving omega-3 fatty acids. Therapy with omega-3 fatty acid preparations should be administered cautiously in patients with hepatic impairment. Serum liver enzyme levels should be monitored periodically.

Nature's Bounty Red Krill Oil (omega-3 polyunsaturated fatty acids) drug interactions

There are 73 drug interactions with Nature's Bounty Red Krill Oil (omega-3 polyunsaturated fatty acids)

More about Nature's Bounty Red Krill Oil (omega-3 polyunsaturated fatty acids)

Related treatment guides

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.